8-K filing — AEMETIS, INC (AMTX)
Filed: 2026-08-06 AccNo: 0001437749-26-026051 Size: 584 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $20
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Aemetis Q2 EPS $(0.13) Beats $(0.28) Estimate, Sales $62.700M Miss $69.498M Estimate
Aemetis (NASDAQ:AMTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.28) by 53.57 percent. This is a 68.29 percent increase over losses of $(0.41) per share from the same
Aemetis' Universal Biofuels Subsidiary Secures ~$17M Order To Provide Over 18M Liters Of Biodiesel To India's Three Federal Oil Marketing Firms
Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, secured allocations to supply more than 18 million liters of